COMBINATION TABLET WITH CHEWABLE OUTER LAYER
First Claim
1. A pharmaceutical composition comprising;
- (a) an inner component comprising an effective amount of a first therapeutic agent, wherein the ingestible component releases the first therapeutic agent by dissolving in stomach, intestines, or further distal in the gastrointestinal tract; and
(b) two or more discrete pulverizable outer layers, each of the discrete pulverizable outer layers comprising at least one second therapeutic agent, the two or more discrete pulverizable outer layers comprising an effective amount of two or more second therapeutic agents, wherein the two or more discrete pulverizable layers are dispersed in the oral cavity by masticating, sucking, dissolving, releasing, or other common means, thereby releasing the two or more second therapeutic agents into the oral cavity where they enter the circulatory system by traversing the buccal mucosa, oral mucosa or combinations thereof;
wherein (a) and (b) further comprise one or more pharmaceutically acceptable excipients, carriers or diluents.
1 Assignment
0 Petitions
Accused Products
Abstract
A pharmaceutical composition in the form of a combination tablet is described. The tablet has a rapidly absorbed component that enters the circulation by traversing the buccal mucosa, oral mucosa and combinations thereof, and a more slowly absorbed component that is swallowed. The therapeutic agent in the swallowed portion is absorbed across the gastric mucosa. The combination tablet may be modified, by varying the specific combinations of excipients, fillers, and the like to effect distinct release rates. In addition, the rapid and slow components may have identical or different therapeutic agents depending on the application to a specific medical condition. One embodiment of the combination tablet includes a prostaglandin inhibitor in the rapidly absorbed component in order to mitigate the side effects of immediate release niacin that is in the slow absorbing component. Such combination compositions will increase patient compliance with various dosing regimens due to the resultant decrease in the number of tablets that a patient would need to take on a daily basis.
48 Citations
23 Claims
-
1. A pharmaceutical composition comprising;
-
(a) an inner component comprising an effective amount of a first therapeutic agent, wherein the ingestible component releases the first therapeutic agent by dissolving in stomach, intestines, or further distal in the gastrointestinal tract; and (b) two or more discrete pulverizable outer layers, each of the discrete pulverizable outer layers comprising at least one second therapeutic agent, the two or more discrete pulverizable outer layers comprising an effective amount of two or more second therapeutic agents, wherein the two or more discrete pulverizable layers are dispersed in the oral cavity by masticating, sucking, dissolving, releasing, or other common means, thereby releasing the two or more second therapeutic agents into the oral cavity where they enter the circulatory system by traversing the buccal mucosa, oral mucosa or combinations thereof; wherein (a) and (b) further comprise one or more pharmaceutically acceptable excipients, carriers or diluents. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
-
11. A pharmaceutical composition comprising;
-
(a) a swallowable portion comprising an effective amount of a first therapeutic agent, wherein the ingestible component releases the first therapeutic agent by dissolving in the stomach, intestines, or further distal in the gastrointestinal tract; and (b) an absorbed-in-mouth portion comprising an effective amount of two or more second therapeutic agents, wherein the absorbed-in-mouth portion is dispersed in the oral cavity by masticating, sucking, dissolving, releasing, or other common means, thereby releasing the two or more second therapeutic agents into the oral cavity where they enter the circulatory system by traversing the oral mucosa buccal mucosa and combinations thereof; wherein (a) and (b) further comprise one or more pharmaceutically acceptable excipients, carriers or diluents. - View Dependent Claims (12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)
-
Specification